Blood test for EBI-3 protein in Behçet's disease
Part of Eyes & vision, Genetic & congenital, Heart & circulation, Mouth & dental, Skin clinical trials.
This study looks at levels of a protein called EBI-3 in the blood of people with Behçet's disease. It may help doctors better understand the disease and could lead to better diagnosis or treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have been diagnosed with Behçet's disease
- You do not have other autoimmune diseases like rheumatoid arthritis, lupus, or psoriatic arthritis
- You do not have an active infection, cancer, liver disease, or advanced kidney disease
- You are not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the health records and blood tests of children and young adults with Behçet disease to learn more about the condition. It also compares their results with healthy children to find clues that may help doctors better understand and treat Behçet disease.
This study looks at how the thickness of the femoral vein wall and certain markers of inflammation relate to Behcet disease. It may help doctors better understand and monitor the condition.
This study looks at a protein called asprosin in people with Behçet's disease. It aims to see if asprosin levels are different in these patients, which could help understand the disease better.
This study tests whether adding a blood thinner (rivaroxaban) to standard immune therapy is better than immune therapy alone for treating blood clots in the legs caused by Behçet's disease. It may help prevent clots from getting worse or recurring.
This Phase 2 trial tests tocilizumab and tofacitinib to see if they can better control vascular (blood-vessel) Behçet’s syndrome. It may help by lowering inflammation and reducing complications from aneurysms in the aorta or peripheral arteries.
This study looks at the symptoms, lab results, and treatments for people with Behçet's disease in Assiut. It aims to improve how the disease is diagnosed and managed.
Hear when a new Behçet Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.